About Bioretec
Bioretec is a company based in Tampere (Finland) founded in 1985. Bioretec has raised $8.58 million across 4 funding rounds from investors including Springvest. The company has 47 employees as of December 31, 2024. Bioretec has completed 1 acquisition, including BRI.Tech. Bioretec offers products and services including RemeOs and Activa. Bioretec operates in a competitive market with competitors including Treace Medical Concepts, Loci Orthopaedics, IlluminOss Medical, Stanmore Implants and Medartis, among others.
- Headquarter Tampere, Finland
- Employees 47 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioretec Ltd.
-
Annual Revenue
$4.72 M (USD)16.32as on Dec 31, 2024
-
Net Profit
-$4.79 M (USD)-21.78as on Dec 31, 2024
-
EBITDA
-$4.21 M (USD)-43.07as on Dec 31, 2024
-
Total Equity Funding
$8.58 M (USD)
in 4 rounds
-
Latest Funding Round
$6.32 M (USD), Post-IPO
Nov 27, 2024
- Investors
-
Employee Count
47
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bioretec
Bioretec is a publicly listed company on the OMXHEX with ticker symbol BRETEC in Finland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Bioretec
Bioretec offers a comprehensive portfolio of products and services, including RemeOs and Activa.
Innovative metal alloy for promoting natural bone healing without removal surgery
Biopolymer products that facilitate bone healing and reduce patient discomfort
People of Bioretec
Unlock access to complete
Unlock access to complete
Funding Insights of Bioretec
Bioretec has successfully raised a total of $8.58M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6.32 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bioretec
Bioretec has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Springvest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Springvest is recognized as a leading growth investment service in Finland.
|
Locked | Locked | Locked |
Investor details for Bioretec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioretec
Bioretec has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BRI.Tech.
Investment portfolio details for Bioretec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Orthopedic surgical instruments are manufactured by BRI.Tech in Germany.
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Bioretec
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Bioretec
Detailed financials for Bioretec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioretec Comparisons
Peer comparison for Bioretec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioretec
Bioretec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Treace Medical Concepts, Loci Orthopaedics, IlluminOss Medical, Stanmore Implants and Medartis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Orthopedic foot and ankle correction systems are developed and offered.
|
|
| Locked | Locked | Locked |
Thumb implant for thumb base arthritis
|
|
| Locked | Locked | Locked |
Minimally invasive orthopedic systems for bone fracture stabilization are developed.
|
|
| Locked | Locked | Locked |
Modular implants for limb sparing and complex primary and revision joint replacement
|
|
| Locked | Locked | Locked |
Metal implants for orthopedic fracture fixation are developed and marketed.
|
Detailed competitors of Bioretec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioretec
Complete news archive for Bioretec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioretec
Bioretec was founded in 1985 and raised its 1st funding round 33 years after it was founded.
Bioretec is headquartered in Tampere, Finland.
Tomi Numminen is the current CEO of Bioretec.
Bioretec is a funded company, having raised a total of $8.58M across 4 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Bioretec is 47.
Annual revenue of Bioretec is $4.72M as on Dec 31, 2024.
Bioretec was founded in 1985 in Tampere, Finland, and operates within the medical device sector. Bioabsorbable, bioactive, and drug-releasing implants are offered, including pins, nails, interference screws, and antibiotic-releasing screws, along with related instruments. These products are utilized for fixing radial head fractures, tibiofibular syndesmosis, bone fractures, osteotomies, and osteochondral fractures, particularly where infection risks from ciprofloxacin-sensitive organisms are present.
Bioretec's top competitors include Treace Medical Concepts, Loci Orthopaedics and Atreon Orthopedics.
Bioretec offers RemeOs and Activa.
Yes, Bioretec is publicly traded on OMXHEX under the ticker symbol BRETEC.
Bioretec has made 1 acquisition, including BRI.Tech.
Bioretec has 1 investor. Key investors include Springvest.
The ticker symbol of Bioretec is BRETEC on OMXHEX.